ArticleRejuvenation research2012

Tissue inhibitor of matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal stem cells enhances cell therapy after myocardial infarction.

Jie Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.